Back to search

Article

In vivo challenges of anti-diabetic peptide therapeutics: Gastrointestinal stability, toxicity and allergenicity

2020-11-01

Abstract excerpt

A plethora of research has explored the potential of bioactive peptide as a new class of drug therapeutics, yet only a minute amount has successfully translated into clinical trials. Possible reasons may include several in vivo challenges such as the poor peptide bioavailability upon oral ingestion, peptide toxicity and peptide allergenicity. Bioinformatics offers a preliminary in silico prediction, screening and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
616f4778-ff33-5d52-abd0-10941413b0b5
DOI
10.1016/j.tifs.2020.09.005
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In vivo challenges of anti-diabetic peptide therapeutics: Gastrointestinal stability, toxicity and allergenicityDOI 10.1016/j.tifs.2020.09.005
Select a neighboring publication to make it the new centre.